Clinical and Prognostic Value of PET/CT Imaging with Combination of ⁶⁸Ga-DOTATATE and ¹⁸F-FDG in Gastroenteropancreatic Neuroendocrine Neoplasms

Figure 3

The overall survival of unresectable patients detected with dual tracers: (a) Kaplan-Meier survival curve for unresectable patients, (A) positive for both tracers, (B) ⁶⁸Ga-DOTA-TATE only, and (C) ¹⁸F-FDG only; (b) unresectable NET patients with ⁶⁸Ga-DOTA-TATE results (positive or negative); (c) unresectable NET patients with ¹⁸F-FDG results (positive or negative); (d) unresectable NEC patients with ⁶⁸Ga-DOTA-TATE results (positive or negative).

(a)

(b)

(c)

(d)